Cryptogenic Stroke in Young Adults: Challenges in Diagnosis and Treatment

Fobian Karen^*
*Correspondence: Fobian Karen, Department of Pediatrics, University of Pittsburgh, Pittsburgh, USA, Email:

Introduction

Stroke, traditionally associated with older adults, is increasingly being recognized as a significant concern among young adults. While stroke in the general population is primarily linked to well-established risk factors such as hypertension, diabetes, and atherosclerosis, the occurrence of stroke in young adults often presents unique challenges. One of the most perplexing phenomena in this demographic is cryptogenic stroke-a type of ischemic stroke where no clear cause can be identified despite comprehensive diagnostic testing. The term "cryptogenic" comes from the Greek word "kryptos," meaning hidden, and reflects the diagnostic uncertainty faced by clinicians when a specific cause remains elusive.

Cryptogenic stroke in young adults-defined as occurring in individuals aged 18 to 50-is particularly concerning due to the lack of obvious risk factors and the potential for devastating long-term effects. As a result, the diagnosis and management of cryptogenic stroke in this population present distinct challenges. This article explores the factors contributing to cryptogenic stroke in young adults, the diagnostic complexities, and the current treatment options, while also discussing potential future approaches to better understand and address this condition.

Description

A stroke occurs when there is a sudden disruption of blood flow to the brain, leading to neuronal injury or death. In ischemic stroke, which is the most common type, a clot or embolus obstructs a blood vessel, depriving part of the brain of oxygen and nutrients. Cryptogenic stroke refers to ischemic strokes for which the underlying cause remains unknown after standard testing, including imaging studies, blood work, and vascular examinations. While strokes in young adults are rare, they are particularly concerning due to the potential lifelong impact. In individuals under 50, the incidence of stroke is about 15-20% of all stroke cases, and many of these are categorized as cryptogenic. The lack of a defined cause complicates treatment and risk assessment for future strokes, making cryptogenic stroke a major challenge for both clinicians and patients.

Though the exact cause of cryptogenic stroke remains unidentified in many cases, several factors and conditions have been proposed as possible contributors. PFO is a congenital heart defect in which there is a hole between the two upper chambers of the heart, allowing blood to bypass the lungs and flow directly into the systemic circulation. This can enable blood clots to reach the brain, causing a stroke. PFO is found in a significant percentage of young stroke patients, particularly those with cryptogenic stroke. However, the exact role of PFO in stroke is debated, with some studies suggesting it is a causal factor, while others argue it is merely a coexisting condition. In young adults, especially those with a history of trauma or sudden neck movements, arterial dissectionsâ??tears in the walls of the arteriesâ??can occur, leading to blood clot formation and subsequent ischemic stroke. These dissections can happen in the vertebral or carotid arteries, which supply blood to the brain. Dissections are often difficult to diagnose and may go unnoticed on initial imaging, adding to the challenges of identifying the stroke's cause.

Some young adults may have an increased tendency to form blood clots, a condition known as hypercoagulability. This can be due to genetic factors such as antithrombin deficiency, protein C or S deficiency, or factor V Leiden mutation, or acquired conditions like antiphospholipid syndrome. Blood clots formed due to hypercoagulability can embolize to the brain and cause stroke, though this can be difficult to identify without specialized testing. Certain genetic conditions, such as Moyamoya disease, a rare condition that causes progressive narrowing of the blood vessels in the brain, can also lead to ischemic strokes in young adults. However, these conditions are often difficult to diagnose in the early stages due to the subtlety of symptoms and the complexity of diagnostic procedures.

In some cases, infections, such as endocarditis (an infection of the heart valves), or autoimmune diseases like lupus, can increase the risk of blood clots and lead to ischemic stroke. However, these conditions may not always be readily identified during initial testing, leading to challenges in diagnosing cryptogenic strokes. Though less common, certain lifestyle factors, including smoking, oral contraceptive use, substance abuse, and stress, can contribute to stroke risk in young adults. These risk factors can lead to conditions like cerebral venous thrombosis or increase the likelihood of a clot forming in the heart or arteries. The diagnosis of cryptogenic stroke is complex and multifaceted. The absence of an identifiable cause after standard diagnostic workup, which includes brain imaging (CT, MRI), vascular imaging, and cardiac investigations, leaves clinicians with uncertainty.

Stroke symptoms in young adults may sometimes be subtle or misattributed to other causes, leading to delayed diagnosis. Headaches, dizziness, or fainting spells may be misinterpreted as symptoms of stress or anxiety, delaying necessary diagnostic tests. Despite advanced imaging technologies such as MRI, CT angiography, and transesophageal echocardiography, certain causes of stroke, such as small embolic events or subtle arterial dissections, may not be immediately visible. Additionally, many of the tests for hypercoagulability and genetic conditions are not routinely performed, further complicating the diagnosis. Cryptogenic strokes often present without the classical risk factors that are seen in older populations, such as high blood pressure or atherosclerosis. This makes the condition harder to identify, and the absence of common stroke risk factors in young adults can lead to underdiagnosis or misdiagnosis.

The treatment of cryptogenic stroke largely depends on the suspected underlying cause, which may remain unknown in many cases. Most young patients with cryptogenic stroke are treated with antiplatelet agents (like aspirin) or anticoagulants (such as warfarin or direct oral anticoagulants). The goal of therapy is to prevent further clot formation and reduce the risk of recurrent stroke. The choice of therapy depends on the suspected etiology, with anticoagulation preferred for patients with a hypercoagulable state or certain cardiac conditions. In cases where PFO is suspected as the cause of the stroke, PFO closure through a catheter-based procedure may be considered, although its effectiveness is still debated. Some studies suggest that PFO closure can reduce the risk of recurrent stroke, while others show no significant benefit compared to medical therapy alone.

Even when no clear cause is found, treating modifiable stroke risk factors such as hypertension, obesity, smoking, and substance abuse is critical. Lifestyle modifications and medication for conditions such as diabetes or hyperlipidemia should also be encouraged. Stroke rehabilitation is essential for young adults who survive a cryptogenic stroke. It focuses on improving motor skills, cognitive function, speech, and overall quality of life. Early intervention with a multidisciplinary rehabilitation team, including physical, occupational, and speech therapists, is key for maximizing recovery. Given the challenges in diagnosing and treating cryptogenic stroke, there is a significant need for further research into the underlying causes and improved diagnostic methods. Advances in genetic testing, the development of biomarkers, and new imaging techniques may allow for earlier detection and more targeted therapies in the future. Additionally, continued exploration into the relationship between lifestyle factors, genetics, and stroke risk in young adults will help refine treatment strategies and prevention programs [1-5].

Conclusion

Cryptogenic stroke in young adults represents a complex and often frustrating diagnostic and treatment challenge. The lack of a clear cause in many cases complicates decision-making, and current diagnostic tools have limitations. Despite these challenges, advances in research and technology continue to shed light on potential causes and offer hope for improved management. By enhancing our understanding of this condition and developing more precise diagnostic methods, we can better support young adults affected by cryptogenic stroke and reduce the long-term impact of this life-altering event. As the field evolves, better identification of at-risk individuals, personalized treatment approaches, and innovative therapeutic options will pave the way for more effective care and improved outcomes for this vulnerable population.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Zoghbi, William A. "Patent foramen ovale: Going beyond the bubbles." JACC Cardiovasc Imaging 7 (2014): 251-253.

Google Scholar        Cross Ref                Indexed at

2. Lechat, P. H., Jean-Louis Mas, Gilles Lascault and P. H. Loron, M. et al. "Prevalence of patent foramen ovale in patients with stroke." N Engl J Med 318 (1988): 1148-1152.

Google Scholar        Cross Ref                Indexed at

3. Orsinelli, David A. and Saurabh Rajpal. "Doing a deep dive on patent foramen ovale: Stay tuned in the PFO world." Cardiovasc Imaging15 (2022): 190-192.

Google Scholar        Cross Ref                Indexed at

4. Trabattoni, Daniela, Marta Brambilla, Paola Canzano and Alessia Becchetti, et al. "Migraine in patients undergoing PFO closure: Characterization of a platelet-associated pathophysiological mechanism: the LEARNER study." Basic Transl Sci 7 (2022): 525-540.

Google Scholar        Cross Ref                Indexed at

5. Othman, Farrah, Brian Bailey, Nicholas Collins and Edmund Lau, et al. "Platypnea�orthodeoxia syndrome in the setting of patent foramen ovale without pulmonary hypertension or major lung disease." J Am Heart Assoc 11 (2022): e024609.

Google Scholar        Cross Ref                Indexed at